HeartFlow Appoints Timothy Barabe to its Board of Directors
REDWOOD CITY, Calif. – January 18, 2022 — HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the appointment of Timothy Barabe to its Board of Directors. “We are honored to have an accomplished leader like Tim join the HeartFlow Board,” said William C. Weldon, Chairman of the Board of Directors, HeartFlow. “Tim’s […]
HeartFlow Files for FDA Clearance of Next Generation Product Offering to Help Evaluate the Presence of Narrowings and Plaque in the Coronary Arteries
Advanced innovations leverage HeartFlow’s core AI technology and are critical additions to HeartFlow’s product portfolio for delivering complete cardiac care
HeartFlow Appoints Dr. Wayne J. Riley to its Board of Directors
HeartFlow Appoints Dr. Wayne J. Riley to its Board of Directors
CMS Sets National Payment Rate for the HeartFlow Analysis in Doctors’ Offices and Imaging Centers
REDWOOD CITY, Calif. – November 3, 2021 — HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the Centers for Medicare & Medicaid Services (CMS) have established a national payment rate of $930.34 for the HeartFlow FFRCT Analysis in office-based settings, such as doctors’ offices and imaging centers, enabling more physicians and patients to gain […]
HeartFlow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as Important Tool in Diagnosing and Treating Heart Disease
HeartFlow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as Important Tool in Diagnosing and Treating Heart Disease
HeartFlow Announces Enrollment of First Two Patients in REVEALPLAQUE Trial
HeartFlow Announces Enrollment of First Two Patients in REVEALPLAQUE Trial
HeartFlow Appoints John Farquhar as Chief Operating Officer
HeartFlow Appoints John Farquhar as Chief Operating Officer
HeartFlow Announces Completion of Patient Enrollment in the PRECISE Trial
HeartFlow Announces Completion of Patient Enrollment in the PRECISE Trial
HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
HeartFlow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease
NICE Renews Support for Use of AI-powered HeartFlow Analysis in Heart Disease Diagnosis
NICE Renews Support for Use of AI-powered HeartFlow Analysis in Heart Disease Diagnosis